PR Newswire - Insilico Received Positive Topline Results from Tw...
Two separate Phase I studies conducted in Australia and in China indicate that ISM5411 was generally safe and well tolerated in all dose groups, demonstrating a favorable PK profile in validating gut...
Read More

ภาษาไทย
English